Biotech U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease March 21, 2025
Biotech Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up March 21, 2025
Biotech Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic March 20, 2025
Biotech Dizal’s Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer March 20, 2025
Biotech DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company’s Prestigious Annual List of the World’s Most Innovative Companies of 2025 March 19, 2025
Biotech Sobi announces a new research collaboration on the development of Gamifant® (emapalumab) in sepsis, which is to be presented at the ISICEM congress March 19, 2025
Biotech Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension March 18, 2025
Biotech iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair March 17, 2025
Biotech iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors March 17, 2025
Search
Biotech
March 22, 2025
March 21, 2025
March 21, 2025
March 20, 2025
March 20, 2025
March 19, 2025
March 19, 2025
March 18, 2025
March 17, 2025
March 17, 2025
